Literature DB >> 23599034

Long term outcome and sequelae in patients after acute thrombotic thrombocytopenic purpura episodes.

T Falter1, K J Alber, I Scharrer.   

Abstract

UNLABELLED: We report on 21 patients with idiopathic thrombotic thrombocytopenic purpura (TTP) whose courses of disease have been followed from the respective diagnosis until now. They had a documented ADAMTS13 activity below 5%, a high autoantibody titer and detectable ultralarge von Willebrand factor (VWF) multimers during their episodes. The initial diagnosis was based on clinical symptoms and on laboratory parameters: thrombocytopenia, haemolytic anaemia, schistocytes and an increased LDH level. 103 acute clinical episodes of 21 TTP-patients during a time period of 30 years are described. Case histories, comorbidities and sequelae were retrospectively documented. RESULTS,
CONCLUSION: Although patients are consistently in a prothrombotic status, clinical acute manifestations only occur after triggering. Most common trigger factors are gastrointestinal infections and pregnancy. The relapse risk per month is 0.026; men have a higher risk for relapses (0.044) than women (0.021). Patients recover physically well, except for renal insufficiency in four cases. Nevertheless, major portion of patients suffers persistently from depression, anxiety disorders and persistent neurocognitive impairments.

Entities:  

Mesh:

Year:  2013        PMID: 23599034     DOI: 10.5482/HAMO-12-11-0019

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  4 in total

1.  Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.

Authors:  Jingrui Sui; Wenjing Cao; Konstantine Halkidis; Mohammad S Abdelgawwad; Nicole K Kocher; Bryan Guillory; Lance A Williams; Radhika Gangaraju; Marisa B Marques; X Long Zheng
Journal:  Blood Adv       Date:  2019-12-23

2.  Increased morbidity during long-term follow-up of survivors of thrombotic thrombocytopenic purpura.

Authors:  Shruti Chaturvedi; Hashim Abbas; Keith R McCrae
Journal:  Am J Hematol       Date:  2015-09-10       Impact factor: 10.047

3.  Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study.

Authors:  Wolfgang Miesbach; Jan Menne; Martin Bommer; Ulf Schönermarck; Thorsten Feldkamp; Martin Nitschke; Timm H Westhoff; Felix S Seibert; Rainer Woitas; Rui Sousa; Michael Wolf; Stefan Walzer; Björn Schwander
Journal:  Orphanet J Rare Dis       Date:  2019-11-15       Impact factor: 4.123

Review 4.  Thrombotic thrombocytopenic purpura.

Authors:  Paul Knöbl
Journal:  Memo       Date:  2018-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.